Immuno-Interception for Patients with High-Risk Cancer.
Journal
Cancer prevention research (Philadelphia, Pa.)
ISSN: 1940-6215
Titre abrégé: Cancer Prev Res (Phila)
Pays: United States
ID NLM: 101479409
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
24
03
2020
revised:
30
03
2020
accepted:
03
04
2020
entrez:
4
6
2020
pubmed:
4
6
2020
medline:
3
6
2021
Statut:
ppublish
Résumé
Cancer immune-interception for prevention of recurrence in patients with high-risk familial cancer like Muir-Torre syndrome or Lynch syndrome using immune checkpoint blockade inhibitors is a promising approach. Albeit, as described in a case report by Pollak and colleagues in the April 2020 issue of
Identifiants
pubmed: 32487723
pii: 1940-6207.CAPR-20-0136
doi: 10.1158/1940-6207.CAPR-20-0136
doi:
Types de publication
Editorial
Comment
Langues
eng
Sous-ensembles de citation
IM
Pagination
493-496Commentaires et corrections
Type : CommentOn
Informations de copyright
©2020 American Association for Cancer Research.